Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant rates » significant facies (Expand Search), significant role (Expand Search), significant risks (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), greater decrease (Expand Search)
Showing 1,861 - 1,880 results of 5,227 for search '(( significant decrease decrease ) OR ( significant rates decrease ))~', query time: 0.40s Refine Results
  1. 1861
    (a) Histogram of relative phase at all steps for all participants.

    (a) Histogram of relative phase at all steps for all participants. by Shinnosuke Hase (20917896)

    Published 2025
    Save to List
    Saved in:
  2. 1862
    SPIRIT-Study Workflow and Assessment Timeline with Primary and Secondary Endpoints.

    SPIRIT-Study Workflow and Assessment Timeline with Primary and Secondary Endpoints. by Haris Omić (21175546)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1863
    Proposed work plan; 1) Blood and 24-hour urine tests including oxalate and citrate analysis, 2) Metabolomics analysis out of blood and urine samples.

    Proposed work plan; 1) Blood and 24-hour urine tests including oxalate and citrate analysis, 2) Metabolomics analysis out of blood and urine samples. by Haris Omić (21175546)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1864
    potential group size calculations based on earlier findings.

    potential group size calculations based on earlier findings. by Haris Omić (21175546)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1865
    Experimental setup.

    Experimental setup. by Shinnosuke Hase (20917896)

    Published 2025
    “…Conversely, the fast-rhythm auditory guide significantly increased step rate and decreased step length (p <  0.05). …”
    Save to List
    Saved in:
  6. 1866
    Win rate vs Skip ratios on multi-agents tasks.

    Win rate vs Skip ratios on multi-agents tasks. by Hongjie Zhang (136127)

    Published 2025
    Save to List
    Saved in:
  7. 1867
    Procedure for attaching the eye drop bottle and instilling eye drops.

    Procedure for attaching the eye drop bottle and instilling eye drops. by Yuka Kasai (21354922)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1868
    Demographics of the enrolled patients.

    Demographics of the enrolled patients. by Yuka Kasai (21354922)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1869
    The video demonstrates how to use the eye drop aid.

    The video demonstrates how to use the eye drop aid. by Yuka Kasai (21354922)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1870
    Overhead view of the eye drop aid.

    Overhead view of the eye drop aid. by Yuka Kasai (21354922)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1871
    Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats.

    Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1872
    Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>

    Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1873
    Summary of cell-based assay EC50 results for WT BMP9 and A347E variant.

    Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1874
    Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.

    Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1875
    Hemodynamic effects of WT BMP9 in rats.

    Hemodynamic effects of WT BMP9 in rats. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1876
    Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.

    Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1877
    <i>In vivo</i> PK evaluation of WT BMP9 in naïve SD rats.

    <i>In vivo</i> PK evaluation of WT BMP9 in naïve SD rats. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1878
    Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>

    Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1879
    Characterization of safety pharmacology of WT BMP9 in rats.

    Characterization of safety pharmacology of WT BMP9 in rats. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1880
    Gene expression levels of <i>CB1R</i>, <i>CB2R</i>, and <i>MAGL</i> in KA-injected mice treated with compound 4f.

    Gene expression levels of <i>CB1R</i>, <i>CB2R</i>, and <i>MAGL</i> in KA-injected mice treated with compound 4f. by Naoto Arimura (416442)

    Published 2024
    Save to List
    Saved in:

Search Tools: